Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
12:23aFLOWR : Hires Lance Emanuel as President
AQ
12:16aGLANCY PRONGAY & MURRAY LLP : Files a Securities Class Action on Behalf of Nobilis Health Corp. Investors
BU
12/14HELIX BIOPHARMA : Fiscal 1Q Earnings Snapshot
AQ
12/14PHARMACYTE BIOTECH : Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)
AQ
12/14HELIX BIOPHARMA CORP. : Announces Fiscal First Quarter 2019 Results
AQ
12/14JOHNSON & JOHNSON : Business Highlights
AQ
12/14INTRINSIC4D : Announces Proposed Share Consolidation, Name Change, and Amendment to Articles
AQ
12/14MARINUS PHARMACEUTICALS,INC. (NASDAQ : MRNS) Files An 8-K Entry into a Material Definitive Agreement
AQ
12/14MARINUS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/14ONCOSEC MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
12/14JOHNSON & JOHNSON : Hagens Berman Notifies Johnson & Johnson (JNJ) Investors of the Firm's Investigation of Possible Disclosure Violations
PR
12/14GERON CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
12/14PULSE BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/14APRICUS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/14SONOMA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Discover
02:38pSHIFA HOSPXD : Transaction of 200 shares of Shifa International Hospitals Limited
AQ
02:38pSHIFA HOSPXD : Transaction of 10,000 shares of Shifa International Hospitals Limited
AQ
02:00pATARA BIOTHERAPEUTICS : Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS)
AQ
01:35pPFIZER : Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV
AQ
01:32pIDERA PHARMACEUTICALS : Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment
AQ
01:28pCHEMESIS INTERNATIONAL INC : . Announces Second Tranche of Convertible Debenture Offering
AQ
01:26pJOHNSON & JOHNSON : Senator Markey Queries FDA on Asbestos and Baby Powder Products
AQ
01:25pAGP : Pakistan Stock Exchange Limited Closing Rate of PHARMACEUTICALS Dated 14-12-2018 - Press Release issued by Pakistan Stock Exchange Limited
AQ
01:13pJOHNSON & JOHNSON : Statement on Reuters Talc Article
AQ
01:12pJOHNSON & JOHNSON : Janssen Submits Supplemental New Drug Application to FDA for XARELTO (Rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
AQ
12:32pALMIRALL : And X-Chem Announce Dermatology-Focused Drug Discovery Collaboration
AQ
12:30pJOHNSON AND JOHNSON PRODUCING DELIBERATELY 'CANCER' CAUSING BABY POWDER FOR YEARS : Report
AQ
12:09pBELLICUM PHARMACEUTICALS : Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO
AQ
12:08pCYNATA THERAPEUTICS : Gets Major Funding From NHMRC For Second Phase Clinical Trial In Osteoarthritis
AQ
12:08pMAX INDIA : KKR-led Radiant in talks to acquire Max Healthcare
AQ
12:08pLEAP THERAPEUTICS : Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tract Cancer
AQ
12:07pJOHNSON & JOHNSON : Wall Street plummets amidst world recession fears
AQ
12:04pORCHARD THERAPEUTICS : and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
AQ
12:04pJOHNSON & JOHNSON : Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
AQ
12:04pORCHARD THERAPEUTICS : and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
AQ
12:04pSANOFI : starts remaining phase 3 clinical trials of Hanmis diabetes drug candidate
AQ
12:04pEXTENDICARE : Announces December 2018 Dividend of C$0.04 per Share
AQ
12:03pCANNABIX TECHNOLOGIES : Cannabis Users Drive High, and Crashes Are on the Rise-- CFN Media
AQ
12:03pSIENNA SENIOR LIVING : Announces December Dividend
AQ
12:03pSENSORION : Announces Positive Topline Results From Seliforant Phase 2a Study
AQ
12:02pAURORA CANNABIS : investing $10M in marijuana retailer High Tide
AQ
12:00pNEUROCRINE BIOSCIENCES : slumps as Tourettes drug fails clinical trial
AQ
12:00pSUPERNUS PHARMACEUTICALS : Announces FDA Approval of sNDA to Expand Oxtellar XR Label to Include Monotherapy
AQ
11:59aLUYE PHARMA : submits its Parkinsons drug for clinical trial approval
AQ
11:58aSECOND SIGHT MEDICAL PRODUCTS : Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
AQ
11:58aFLOWR : Hires Lance Emanuel as President
AQ
11:12aBERGENBIO : announces a change to its Board of Directors
AQ
10:18aSONOMA PHARMACEUTICALS : Announces Management Changes
AQ
10:18aALDER BIOPHARMACEUTICALS : Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
10:17aPARADIGM BIOPHARMACEUTICALS : has results pending for phase 2b clinical trial
AQ
10:16aFRESENIUS MEDICAL CARE : acquires additional renal hospitals and dialysis centers in China
AQ
10:16aKALVISTA PHARMACEUTICALS : Reports Fiscal Second Quarter Results
AQ
09:16aCURALEAF : Md. medical pot regulators plan hearing on rules many fear threaten competition
AQ
09:01aROCHE : Genentech Develop Antibiotic Effective Against Gram-Negative Bacteria, with Potential to Lead to New Class of Antibiotics
AQ
08:31aBeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress
GL
07:42aJOHNSON & JOHNSON : Stocks plunge to 8-month lows
AQ
06:50aEPIZYME : Family of Lakewood toddler with brain tumor desperate for unapproved drug
AQ
04:51aHENRY SCHEIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL : Kahn Swick & Foti, LLC Investigates the Officers and Directors of Henry Schein, Inc. - HSIC
BU
02:10aMedicenna Announces Pricing of Marketed Offering of Units
NE
01:22aJOHNSON & JOHNSON : Global growth worries, J&J's tumble drag Wall St lower
AQ
12:39aGLANCY PRONGAY & MURRAY LLP : Announces Extended Class Period in Securities Class Action on Behalf of Align Technology, Inc. Investors
BU
12:32aTEVA PHARMACEUTICAL INDUSTRIES : Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER2-Overexpressing Breast Cancer for Certain Indications
BU
12:25aAbattis Bioceuticals Corp., A Fully Integrated Medical Marijuana Company, CEO Clip Video
NE
12:25aABATTIS BIOCEUTICALS CORP. : A Fully Integrated Medical Marijuana Company, CEO Clip Video
AQ
12/14MEDICARE : Israeli soldiers injure Palestinian by live shots near Hebron
AQ
04:36pSupreme Court freezes Rs 4,000 crore IHH-Fortis deal over Daiichi plea
AQ
04:31pJOHNSON & JOHNSON : Claims company knew of asbestos
AQ
04:07pUNITEDHEALTH : New tax on nonprofit salaries means less money going to the mission
AQ
02:45pBUMRUNGRAD HOSPITAL PUBLIC : PM condoles death of film director Amjad Hossain
AQ
02:38pHIGHNOON LAB : Transaction of 15,000 shares of Highnoon Laboratories Limited
AQ
1  2  3  4  5  6  7  8  9  10Next
Advertisement